Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. It also offers parasiticides, vaccines, dermatology, other pharmaceutical, anti-infectives, animal health diagnostics, and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaboration Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was founded in 1952 and is headquartered in Parsippany, New Jersey.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-05-02 |
2024-03 |
1.35 |
N/A |
N/A |
N/A |
2024-02-13 |
2023-12 |
1.33 |
1.24 |
-0.09 |
-6.77% |
2023-11-02 |
2023-09 |
1.35 |
1.36 |
0.01 |
0.74% |
2023-08-08 |
2023-06 |
1.32 |
1.41 |
0.09 |
6.82% |
2023-05-04 |
2023-03 |
1.27 |
1.31 |
0.04 |
3.15% |
2023-02-14 |
2022-12 |
1.15 |
1.15 |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2023-09-11 |
Stifel |
Upgrade |
Buy |
Buy |
2023-09-05 |
HSBC |
Upgrade |
|
Buy |
2023-08-27 |
Stifel |
Upgrade |
Buy |
Buy |
2023-08-13 |
Piper Sandler |
Upgrade |
Overweight |
Overweight |
2023-08-09 |
Goldman Sachs |
Upgrade |
Buy |
Buy |
2023-06-13 |
Atlantic Equities |
Upgrade |
Overweight |
Overweight |
Date |
Name |
Relation |
Quantity |
Description |
2024-02-08 |
BISARO PAUL M. |
Director |
21.78K |
Conversion of Exercise of derivative security |
2024-02-08 |
D AMELIO FRANK A |
Director |
0.00 |
Conversion of Exercise of derivative security |
2024-03-17 |
LAGANO ROXANNE |
Officer |
16.52K |
Sale |
2024-02-08 |
MCCALLISTER MICHAEL B |
Director |
25.86K |
Conversion of Exercise of derivative security |
2024-02-20 |
NORDEN GREGORY |
Director |
15.11K |
Stock Gift |
2024-02-08 |
PARENT LOUISE M |
Director |
13.74K |
Conversion of Exercise of derivative security |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Group Inc |
39.74M |
6.84B |
8.63% |
2023-06-29 |
Blackrock Inc. |
38.17M |
6.57B |
8.29% |
2023-06-29 |
State Street Corporation |
19.63M |
3.38B |
4.26% |
2023-06-29 |
State Farm Mutual Automobile Insurance Co |
17.13M |
2.95B |
3.72% |
2023-06-29 |
Alliancebernstein L.P. |
16.12M |
2.78B |
3.50% |
2023-06-29 |
Capital International Investors |
15.26M |
2.63B |
3.32% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Total Stock Market Index Fund |
12.98M |
2.24B |
2.82% |
2023-06-29 |
Vanguard 500 Index Fund |
11.00M |
1.89B |
2.39% |
2023-06-29 |
Growth Fund Of America Inc |
6.06M |
1.04B |
1.32% |
2023-06-29 |
New Perspective Fund Inc |
5.39M |
927.60M |
1.17% |
2023-05-30 |
Fidelity 500 Index Fund |
5.22M |
850.16M |
1.13% |
2023-08-30 |
SPDR S&P 500 ETF Trust |
5.09M |
969.51M |
1.11% |
Dividend |
Date |
0.432 |
2024-04-18 |
0.432 |
2024-01-18 |
0.375 |
2023-10-31 |
0.375 |
2023-07-20 |
1.5 |
2023-04-20 |
0.375 |
2023-01-19 |